These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12439350)

  • 21. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T; Takeshita A
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta blockers in severe heart failure. Prognosis improves already after a short time].
    MMW Fortschr Med; 2002 Apr; 144(15):62. PubMed ID: 12013032
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging trends in the management of heart failure: Beta blocker therapy.
    Sauls JL; Rone T
    Nurs Clin North Am; 2005 Mar; 40(1):135-48. PubMed ID: 15733952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective beta-blockers and mortality from heart failure.
    Seth S; Naik N; Mohan A
    Natl Med J India; 1999; 12(5):225-6. PubMed ID: 10613003
    [No Abstract]   [Full Text] [Related]  

  • 26. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
    Gattis WA; O'Connor CM; Gheorghiade M
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S48-54. PubMed ID: 12447162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Severe heart failure. Carvedilol lowers mortality].
    MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
    [No Abstract]   [Full Text] [Related]  

  • 31. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 33. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
    Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
    Stecker EC; Fendrick AM; Knight BP; Aaronson KD
    Am Heart J; 2006 Apr; 151(4):820-8. PubMed ID: 16569541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ
    Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with beta blockers in heart failure mortality trials.
    Eichhorn EJ
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V21-9. PubMed ID: 10526700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.